How much does one month of treatment with Inavolisib cost?

Inavolisib (Inavolisib) is the world's first new-generation PI3Kα inhibitor designed specifically for PIK3CA-mutated breast cancer . Its research and development costs and clinical value determine its high pricing on the market. The drug is currently on the market in some countries, but it has not been officially included in the medical insurance reimbursement system in mainland China. Therefore, if patients need to use it, they usually need to purchase it through imported drug channels. In overseas markets, a box of the original drug Inavolisib sells for about 200,000 yuan. The specific price may fluctuate due to changes in national policies, channels and exchange rates.

From the perspective of medication cycle, inalisate is in the form of oral tablets, once daily. When used in combination with fulvestrant, the treatment course is usually calculated as a cycle of 28 days. Calculated based on standard dosage, one month's drug expenditure is approximately between 200,000 and 250,000 yuan. For some patients, this cost burden is relatively large, so whether it is included in medical insurance is the key to future clinical application promotion.

It is worth noting that inaliset has optimized pharmacokinetic characteristics in drug design, making it have a longer half-life, higher medication compliance, and reducing metabolic side effects caused by traditionalPI3K inhibitors, such as hyperglycemia and gastrointestinal discomfort. For this reason, despite its higher price, in clinical practice it is regarded as a precision-targeted drug with long-term application potential.

Currently, there are no generic drugs on the market at home or abroad, and import channels mainly rely on the supply system of European and American pharmaceutical companies. Some cross-border pharmacies and compliant import platforms can provide American or European versions of Inarisep. The price differences are mainly due to regional pricing policies and exchange rate changes. For patients with financial conditions, choosing original drugs can ensure the quality and stable efficacy of the drugs.

Reference materials:https://www.itovebi-hcp.com/